Article

Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol

2024-02-20

Abstract excerpt

<h4>Background: </h4> The burden of herpes zoster (shingles) virus and associated complications, such as post-herpetic neuralgia, is higher in older adults and has a significant impact on quality of life. The incidence of herpes zoster and post-herpetic neuralgia is increased in people living with HIV (PLWH) compared to an age-matched general population, including PLWH on long-term antiretroviral therapy (ART) wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f00175e4-ded9-5cea-a34f-5daaffe71dbc
DOI: 10.21203/rs.3.rs-3955771/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocolDOI 10.21203/rs.3.rs-3955771/v1Read

Efficacy and side effects of the Herpes Zoster vaccine in immunocompromised individuals – a systematic reviewSemantic proximity Read

Recombinant Zoster Vaccine Uptake and Risk of Flares Among Older Adults With Immune‐Mediated Inflammatory Diseases in the USSemantic proximity Read

Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune DiseasesSemantic proximity Read

Epidemiology and clinical profile of herpes zoster in the varicella vaccine era: A case series studySemantic proximity Read

Unraveling the immune signature of herpes zoster: Insights into pathophysiology and the HLA risk profileSemantic proximity Read

Identification and characterization of CD4+ T cell epitopes after Shingrix vaccinationSemantic proximity Read

Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year PersistenceSemantic proximity Read

Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in HumansSemantic proximity Read

Unraveling the Immune Signature of Herpes Zoster: Insights Into the Pathophysiology and Human Leukocyte Antigen Risk Profile.Semantic proximity Read

Broadly Reactive Human CD8 T Cells that Recognize an Epitope Conserved between VZV, HSV and EBVSemantic proximity Read

Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell RepertoireSemantic proximity Read

Immunogenicity and Safety of Inactivated SARS-CoV-2 Vaccine in People Living with HIV: A Cross-Sectional StudySemantic proximity Read